Bills › 88th General Assembly
Relating to controlled substances, including amending information collection and reporting requirements under the Iowa prescription monitoring program, amending the controlled substance schedules, removing certain references to marijuana, making penalties applicable, and including effective date provisions
Sponsored by the Senate State Government Committee
Topics:State governmentHealth care
Where it is now
- Done: IntroducedMarch 11, 2019
- Skipped: SubcommitteeSkipped
- Done: Senate committeeMarch 11, 2019
- Done: Passes the SenateMarch 21, 201946–0
- Done: House committeeApril 4, 2019
- Done: Passes the HouseApril 18, 2019
- Stopped: To the GovernorDied when the General Assembly ended
- Next: Signed into law
Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
DIVISION I —— IOWA PRESCRIPTION MONITORING PROGRAM INFORMATION REPORTING. This division expands reporting to the Iowa prescription monitoring program (PMP) to include those controlled substances in schedules III, IV, and V under the Iowa uniform controlled substances Act (Act) which are dispensed to patients in Iowa. This bill requires all dispensations of schedules III, IV, and V controlled substances, including those that do not require a prescription to be dispensed by a pharmacist, to be reported to the PMP, except for dispensations of pseudoephedrine, which are reported to the real-time electronic repository.
Read the full explanation
The division also extends the reporting requirement to other prescription substances that the board of pharmacy and the PMP advisory council determine could be addictive or fatal if not taken under the care and direction of a prescribing practitioner. The division also changes the due date for annual reports to the governor and legislature regarding the PMP from January to February 1. DIVISION II —— CONTROLLED SUBSTANCE SCHEDULES.1 percent tetrahydrocannabinols to schedule V of the Act. The division designates all products which contain derivatives of barbituric acid (butalbital) as schedule III controlled substances under the Act, subject to reporting to the PMP. The division strikes language referring to medical marijuana programs of the board of pharmacy. The division becomes effective upon enactment.
Changed since by amendment H-1226; see Amendments.
Iowa Code it changes
Lobbying
4 for · 1 against · 39 undecided · Who →
Family tree
88th General Assembly